HYDERABAD, India, Aug. 26, 2025 /PRNewswire/ — According to DataM Intelligence, the global neurology devices market reached US$ 23.95 billion in 2023, with a rise to US$ 25.30 billion in 2024, and is expected to reach US$ 43.28 billion by 2033, growing at a CAGR of 6.2% during the forecast period 2025–2033.
DataM Intelligence 4Market Research LLP – Logo (PRNewsfoto/DataM Intelligence)
As neurological disorders continue to rise worldwide, the demand for innovative, reliable, and minimally invasive neurology devices has never been greater. Cutting-edge technologies are transforming patient care and enabling healthcare providers to deliver faster, more precise treatments. With North America leading the way through strong investments and supportive healthcare policies, and Asia Pacific rapidly advancing in healthcare access and innovation, there’s a tremendous opportunity to improve outcomes on a global scale. Today’s healthcare providers require solutions that combine precision, ease of use, and minimally invasive approaches to improve diagnosis, treatment, and patient quality of life. From state-of-the-art neuroimaging and implantable neuromodulation devices to innovative wearable diagnostics, these technologies are revolutionizing neurological care by enabling earlier detection and more targeted therapies.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response) – https://www.datamintelligence.com/download-sample/neurology-devices-market
AI-Powered Brain Stimulation Enhances Treatment Precision
Technological advancements are revolutionizing the neurology devices market, particularly in brain stimulation. The Mayo Clinic, in collaboration with Google Research, has developed an AI-driven algorithm to improve brain stimulation devices for treating movement and psychological disorders like epilepsy. Unlike traditional methods that focus on specific brain regions, this algorithm captures the complex dynamics of entire brain networks, offering a more comprehensive approach to treatment. This innovation is poised to enhance the effectiveness of therapies for conditions such as depression, traumatic brain injury, and bipolar disorder.
Implantable Wireless Devices Lead the Way
Manufacturers are heavily investing in research and development to create implantable wireless brain devices. These small, wireless neuromodulators, implanted inside the skull, connect with the brain to stimulate nerves throughout the body. Equipped with antennae, application-specific integrated circuits, and ceramic covers, these devices modify brain impulses to treat a range of neurological and psychiatric conditions. For example, Medtronic’s $1,200 crore investment in its Hyderabad R&D center in August 2020 aims to make it the company’s second-largest research hub within five years, driving further innovation in neuromodulation technologies.